查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1544658

綿羊及山羊人工授精市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Ovine and Caprine Artificial Insemination Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 185 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在生殖技術進步和對改善牲畜遺傳學的關注的推動下，全球綿羊和山羊人工授精市場在 2024 年至 2032 年間將實現 5.8% 的複合年成長率。創新人工智慧技術的整合提高了綿羊和山羊族群的生育率和遺傳多樣性，滿足了對優質肉類和牛奶不斷成長的需求。在此背景下，2024年1月，農業、食品安全和企業部（MAFSE）宣布，台灣與伯利茲於2015年12月啟動的綿羊和山羊基因改良計畫取得了重大進展。該措施旨在透過綜合方法改善品種品質、基礎設施和農民教育，從而提升伯利茲的小型反芻動物部門。

此外，商業畜牧業的擴張以及農民對人工智慧好處的認知不斷提高，也有助於市場成長，因為這些做法可以實現更好的畜群管理和生產力。

綿羊和山羊人工授精市場根據類型、動物類型、技術、最終用途和地區進行細分。

由於擴大採用需要精確可靠工具的複雜生殖技術，設備領域將在 2032 年顯著成長。隨著農民和育種者尋求最佳化生育力並確保成功的授精程序，對提高準確性、效率和易用性的先進設備的需求變得至關重要。人們對育種過程中技術精度的日益關注推動了對高品質設備的需求，這些設備旨在支援成功的人工智慧實踐並提高牲畜生產力。

由於山羊在不同農業領域中的作用不斷擴大，到 2032 年，山羊/山羊細分市場將佔據顯著的收入佔有率。隨著對肉、乳和纖維等山羊產品的需求增加，對提高畜群品質和生產力的有效育種方法的需求也隨之增加。對增強山羊遺傳性狀的重視促進了人工授精技術的採用，促進了山羊族群的更好管理和最佳化。

在政府對先進農業實踐的支持和資助不斷增加的推動下，2024年至2032年歐洲綿羊和山羊人工授精產業將呈現顯著成長。隨著歐洲國家注重提高畜牧業生產力和永續性，旨在推廣現代育種技術的政策和補貼發揮至關重要的作用。消費者對優質綿羊和山羊產品的需求不斷成長，也鼓勵農民採用人工授精來改善畜群遺傳並滿足需求。對改善動物福利和減少育種相關挑戰的重視支持了整個地區綿羊和山羊人工授精市場的擴大。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 肉類和乳製品消費量上升
      • 人工授精技術的創新
      • 政府和農業組織的支持
    • 產業陷阱與挑戰
      • 手續費用高
      • 在某些地區獲得技術的機會有限
  • 成長潛力分析
  • 技術景觀
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

  • 主要趨勢
  • 裝置
  • 精液
    • 正常精液
    • 性精液
  • 試劑及試劑盒
  • 服務

第 6 章：市場估計與預測：按動物類型，2021 - 2032

  • 主要趨勢
  • 綿羊/綿羊
  • 山羊/山羊

第 7 章：市場估計與預測：按技術分類，2021 - 2032 年

  • 主要趨勢
  • 陰道
  • 子宮頸
  • 宮內

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 獸醫院
  • 獸醫診所
  • 其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 波蘭
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Agtech, Inc.
  • B and D Genetics
  • Continental Genetics, LLC
  • IMV Technologies Group
  • Jorgensen Laboratories
  • MINITUB GMBH
  • Neogen Corporation
  • Nasco
  • Reproduction Provisions LLC
  • SEK Genetics
  • Zoetis Inc.
簡介目錄
Product Code: 10193

Global Ovine and Caprine Artificial Insemination Market will experience a 5.8% CAGR between 2024 and 2032, driven by advancements in reproductive technologies and a focus on improving livestock genetics. The integration of innovative AI techniques enhances fertility rates and genetic diversity in sheep and goat populations, meeting the rising demand for high-quality meat and milk. Against this backdrop, in January 2024, the Ministry of Agriculture, Food Security, and Enterprise (MAFSE) announced that the Genetic Improvement in Sheep and Goat Project, a Taiwan-Belize collaboration launched in December 2015, has made significant strides. This initiative aims to elevate Belize's small ruminant sector by improving breed quality, infrastructure, and farmer education through a comprehensive approach.

Additionally, the expansion of commercial livestock farming and the increasing awareness among farmers about the benefits of AI contribute to market growth, as these practices enable better herd management and productivity.

The ovine and caprine artificial insemination market is segmented based on type, animal type, technique, end-use, and region.

The equipment segment will record a significant growth rate through 2032, owing to the growing adoption of sophisticated reproductive technologies that require precise and reliable tools. As farmers and breeders seek to optimize fertility and ensure successful insemination procedures, the need for advanced equipment that offers improved accuracy, efficiency, and ease of use becomes crucial. This increased focus on technological precision in the breeding process drives the demand for high-quality equipment designed to support successful AI practices and improve livestock productivity.

The caprine/goat segment will acquire a noteworthy revenue share by 2032, due to the expanding role of goats in diverse agricultural sectors. As demand for goat products such as meat, milk, and fiber increases, so does the need for effective breeding methods to improve herd quality and productivity. The emphasis on enhancing genetic traits in goats ushers in the adoption of artificial insemination techniques, facilitating better management and optimization of goat populations.

Europe ovine and caprine artificial insemination industry will show a significant growth rate from 2024 to 2032, driven by increasing government support and funding for advanced agricultural practices. As European countries focus on enhancing livestock productivity and sustainability, policies, and subsidies aimed at promoting modern breeding technologies play a crucial role. The rising consumer demand for high-quality sheep and goat products also encourages farmers to adopt artificial insemination to improve herd genetics and meet needs. The emphasis on improving animal welfare and reducing breeding-related challenges supports the expansion of the ovine and caprine artificial insemination market across the region.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising meat and dairy consumption
      • 3.2.1.2 Innovations in artificial insemination techniques
      • 3.2.1.3 Support from governments and agricultural organizations
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of procedures
      • 3.2.2.2 Limited access to technology in certain regions
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Future market trends
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Equipment
  • 5.3 Semen
    • 5.3.1 Normal semen
    • 5.3.2 Sexed semen
  • 5.4 Reagent and kits
  • 5.5 Services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Ovine/sheep
  • 6.3 Caprine/goat

Chapter 7 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Vaginal
  • 7.3 Cervical
  • 7.4 Intrauterine

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Veterinary hospitals
  • 8.3 Veterinary clinics
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Poland
    • 9.3.7 Netherlands
    • 9.3.8 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Agtech, Inc.
  • 10.2 B and D Genetics
  • 10.3 Continental Genetics, LLC
  • 10.4 IMV Technologies Group
  • 10.5 Jorgensen Laboratories
  • 10.6 MINITUB GMBH
  • 10.7 Neogen Corporation
  • 10.8 Nasco
  • 10.9 Reproduction Provisions LLC
  • 10.10 SEK Genetics
  • 10.11 Zoetis Inc.